Is DBV Technologies (EPA:DBV) In A Good Position To Invest In Growth?
Dec 01
French (CAC) Biotech Industry Analysis
UpdatedDec 05, 2023
DataAggregated Company Financials
Companies29
- 7D-0.3%
- 3M-23.8%
- 1Y-10.4%
- YTD-13.4%
Over the last 7 days, the Biotech industry has dropped 1.3%, driven by declines in DBV Technologies and Acticor Biotech SAS of 7.7% and 22%, respectively. The industry has fallen 9.9% in the last year. As for the next few years, earnings are expected to grow by 46% per annum.
Industry Valuation and Performance
Has the French Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 05 Dec 2023 | €3.2b | €594.7m | -€685,255,395.00 | 21.7x | -4.6x | 5.3x |
| Thu, 02 Nov 2023 | €3.1b | €803.5m | -€567,784,769.00 | 21x | -5.5x | 3.9x |
| Sat, 30 Sep 2023 | €3.3b | €827.5m | -€579,145,511.00 | 14.2x | -5.8x | 4x |
| Mon, 28 Aug 2023 | €3.7b | €818.2m | -€727,289,207.00 | 24.1x | -5.1x | 4.5x |
| Wed, 26 Jul 2023 | €3.8b | €817.5m | -€734,744,130.00 | 24.5x | -5.2x | 4.6x |
| Fri, 23 Jun 2023 | €3.9b | €819.7m | -€742,987,860.00 | 25.3x | -5.3x | 4.8x |
| Sun, 21 May 2023 | €3.8b | €831.2m | -€761,674,629.00 | 26.1x | -4.9x | 4.5x |
| Tue, 18 Apr 2023 | €3.5b | €878.2m | -€769,875,315.00 | 31.6x | -4.5x | 4x |
| Thu, 16 Mar 2023 | €3.3b | €1.0b | -€470,273,558.00 | 9.7x | -7x | 3.2x |
| Sat, 11 Feb 2023 | €3.7b | €1.0b | -€457,392,283.00 | 11.5x | -8.1x | 3.5x |
| Mon, 09 Jan 2023 | €3.7b | €1.0b | -€455,883,646.00 | 12.1x | -8x | 3.5x |
| Wed, 07 Dec 2022 | €3.5b | €1.0b | -€457,899,023.00 | 12.6x | -7.5x | 3.3x |
| Fri, 04 Nov 2022 | €3.6b | €914.4m | -€705,389,452.00 | 16.5x | -5.1x | 3.9x |
| Sun, 02 Oct 2022 | €3.2b | €923.3m | -€677,984,751.00 | 31x | -4.7x | 3.5x |
| Tue, 30 Aug 2022 | €4.4b | €930.8m | -€751,667,630.00 | 115x | -5.8x | 4.7x |
| Thu, 28 Jul 2022 | €4.4b | €985.5m | -€688,213,309.00 | 120.9x | -6.3x | 4.4x |
| Sat, 25 Jun 2022 | €4.7b | €993.1m | -€693,029,894.00 | 126x | -6.7x | 4.7x |
| Mon, 23 May 2022 | €4.7b | €991.3m | -€692,391,260.00 | 134.4x | -6.8x | 4.8x |
| Wed, 20 Apr 2022 | €5.1b | €1.2b | -€489,700,261.00 | 3x | -10.5x | 4.2x |
| Fri, 18 Mar 2022 | €5.5b | €950.8m | -€648,046,770.00 | 17.4x | -8.5x | 5.8x |
| Sun, 13 Feb 2022 | €5.4b | €929.8m | -€675,308,815.00 | 3x | -7.9x | 5.8x |
| Tue, 11 Jan 2022 | €6.1b | €931.7m | -€678,654,271.00 | 3.2x | -9x | 6.5x |
| Thu, 09 Dec 2021 | €6.9b | €923.1m | -€680,995,918.00 | 2.7x | -10.1x | 7.4x |
| Sat, 06 Nov 2021 | €6.5b | €921.3m | -€672,182,761.00 | 2.3x | -9.7x | 7.1x |
| Mon, 04 Oct 2021 | €6.8b | €902.4m | -€738,666,719.00 | 2.6x | -9.2x | 7.5x |
| Wed, 01 Sep 2021 | €7.7b | €899.6m | -€600,532,159.12 | 2.9x | -12.8x | 8.5x |
| Thu, 08 Jul 2021 | €6.5b | €899.6m | -€600,532,159.12 | 2.8x | -10.8x | 7.2x |
| Wed, 31 Mar 2021 | €6.9b | €882.0m | -€570,006,611.92 | 4x | -12.1x | 7.8x |
| Sat, 02 Jan 2021 | €6.5b | €911.8m | -€514,619,691.42 | 21.4x | -12.6x | 7.1x |
Price to Earnings Ratio
-12.6x
Current Industry PE
- Investors are relatively neutral on the French Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 5.5x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have deteriorated over the last three years.
- Revenues have also declined 6.9% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Trends
Which industries have driven the changes within the French Healthcare industry?
| FR Market | 0.43% | |
| Healthcare | 0.31% | |
| Biotech | -0.27% | |
| Biotech | -0.27% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ABVX ABIVAX Société Anonyme | €9.40 | 1.6% +€9.4m | 41.1% | PS29443.6x | |
| ALCLS Cellectis | €2.65 | 3.1% +€5.7m | 22.4% | PS8.4x | |
| VLA Valneva | €5.22 | 0.7% +€5.3m | -25.2% | PS3.2x | |
| ADOC Adocia | €8.23 | 4.8% +€5.3m | 165.1% | PS10.5x | |
| MAAT MaaT Pharma | €7.00 | 2.9% +€2.3m | -22.2% | PS35.1x |
